✉  info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Antihistamine Drugs Market Research Report: Information by Type (Sedating and Non-Sedating), By Route of Administration (Oral Route, Parenteral Route, and Rectal Route), By Indication (Allergy, Urticaria, and Dermatitis), By End User (Hospitals, Clinics, and Pharmaceutical Companies), And by Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032


ID: MRFR/Pharma/2913-HCR | 206 Pages | Author: Rahul Gotadki| December 2024

Market Segmentation


Antihistamine Drugs Type Outlook (USD Billion, 2018-2032)




  • Sedating




  • Non-Sedating




Antihistamine Drugs Route of Administration Outlook (USD Billion, 2018-2032)




  • Oral Route




  • Parenteral Route




  • Rectal Route




Antihistamine Drugs Indication Outlook (USD Billion, 2018-2032)




  • Allergy




  • Urticaria




  • Dermatitis




Antihistamine Drugs End User Outlook (USD Billion, 2018-2032)




  • Hospitals




  • Clinics




  • Pharmaceutical Companies




Antihistamine Drugs Regional Outlook (USD Billion, 2018-2032)




  • North America Outlook (USD Billion, 2018-2032)




    • North America Antihistamine Drugs by Type




      • Sedating




      • Non-Sedating






    • North America Antihistamine Drugs by Route of Administration




      • Oral Route




      • Parenteral Route




      • Rectal Route






    • North America Antihistamine Drugs by Indication




      • Allergy




      • Urticaria




      • Dermatitis






    • North America Antihistamine Drugs by End User




      • Hospitals




      • Clinics




      • Pharmaceutical Companies






    • US Outlook (USD Billion, 2018-2032)




    • US Antihistamine Drugs by Type




      • Sedating




      • Non-Sedating






    • US Antihistamine Drugs by Route of Administration




      • Oral Route




      • Parenteral Route




      • Rectal Route






    • US Antihistamine Drugs by Indication




      • Allergy




      • Urticaria




      • Dermatitis






    • US Antihistamine Drugs by End User




      • Hospitals




      • Clinics




      • Pharmaceutical Companies






    • Canada Outlook (USD Billion, 2018-2032)




    • Canada Antihistamine Drugs by Type




      • Sedating




      • Non-Sedating






    • Canada Antihistamine Drugs by Route of Administration




      • Oral Route




      • Parenteral Route




      • Rectal Route






    • Canada Antihistamine Drugs by Indication




      • Allergy




      • Urticaria




      • Dermatitis






    • Canada Antihistamine Drugs by End User




      • Hospitals




      • Clinics




      • Pharmaceutical Companies








  • Europe Outlook (USD Billion, 2018-2032)




    • Europe Antihistamine Drugs by Type




      • Sedating




      • Non-Sedating






    • Europe Antihistamine Drugs by Route of Administration




      • Oral Route




      • Parenteral Route




      • Rectal Route






    • Europe Antihistamine Drugs by Indication




      • Allergy




      • Urticaria




      • Dermatitis






    • Europe Antihistamine Drugs by End User




      • Hospitals




      • Clinics




      • Pharmaceutical Companies






    • Germany Outlook (USD Billion, 2018-2032)




    • Germany Antihistamine Drugs by Type




      • Sedating




      • Non-Sedating






    • Germany Antihistamine Drugs by Route of Administration




      • Oral Route




      • Parenteral Route




      • Rectal Route






    • Germany Antihistamine Drugs by Indication




      • Allergy




      • Urticaria




      • Dermatitis






    • Germany Antihistamine Drugs by End User




      • Hospitals




      • Clinics




      • Pharmaceutical Companies






    • France Outlook (USD Billion, 2018-2032)




    • France Antihistamine Drugs by Type




      • Sedating




      • Non-Sedating






    • France Antihistamine Drugs by Route of Administration




      • Oral Route




      • Parenteral Route




      • Rectal Route






    • France Antihistamine Drugs by Indication




      • Allergy




      • Urticaria




      • Dermatitis






    • France Antihistamine Drugs by End User




      • Hospitals




      • Clinics




      • Pharmaceutical Companies






    • UK Outlook (USD Billion, 2018-2032)




    • UK Antihistamine Drugs by Type




      • Sedating




      • Non-Sedating






    • UK Antihistamine Drugs by Route of Administration




      • Oral Route




      • Parenteral Route




      • Rectal Route






    • UK Antihistamine Drugs by Indication




      • Allergy




      • Urticaria




      • Dermatitis






    • UK Antihistamine Drugs by End User




      • Hospitals




      • Clinics




      • Pharmaceutical Companies






    • Italy Outlook (USD Billion, 2018-2032)




    • Italy Antihistamine Drugs by Type




      • Sedating




      • Non-Sedating






    • Italy Antihistamine Drugs by Route of Administration




      • Oral Route




      • Parenteral Route




      • Rectal Route






    • Italy Antihistamine Drugs by Indication




      • Allergy




      • Urticaria




      • Dermatitis






    • Italy Antihistamine Drugs by End User




      • Hospitals




      • Clinics




      • Pharmaceutical Companies






    • Spain Outlook (USD Billion, 2018-2032)




    • Spain Antihistamine Drugs by Type




      • Sedating




      • Non-Sedating






    • Spain Antihistamine Drugs by Route of Administration




      • Oral Route




      • Parenteral Route




      • Rectal Route






    • Spain Antihistamine Drugs by Indication




      • Allergy




      • Urticaria




      • Dermatitis






    • Spain Antihistamine Drugs by End User




      • Hospitals




      • Clinics




      • Pharmaceutical Companies






    • Rest Of Europe Outlook (USD Billion, 2018-2032)




    • Rest Of Europe Antihistamine Drugs by Type




      • Sedating




      • Non-Sedating






    • Rest Of Europe Antihistamine Drugs by Route of Administration




      • Oral Route




      • Parenteral Route




      • Rectal Route






    • Rest Of Europe Antihistamine Drugs by Indication




      • Allergy




      • Urticaria




      • Dermatitis






    • Rest Of Europe Antihistamine Drugs by End User




      • Hospitals




      • Clinics




      • Pharmaceutical Companies








  • Asia-Pacific Outlook (USD Billion, 2018-2032)




    • Asia-Pacific Antihistamine Drugs by Type




      • Sedating




      • Non-Sedating






    • Asia-Pacific Antihistamine Drugs by Route of Administration




      • Oral Route




      • Parenteral Route




      • Rectal Route






    • Asia-Pacific Antihistamine Drugs by Indication




      • Allergy




      • Urticaria




      • Dermatitis






    • Asia-Pacific Antihistamine Drugs by End User




      • Hospitals




      • Clinics




      • Pharmaceutical Companies






    • China Outlook (USD Billion, 2018-2032)




    • China Antihistamine Drugs by Type




      • Sedating




      • Non-Sedating






    • China Antihistamine Drugs by Route of Administration




      • Oral Route




      • Parenteral Route




      • Rectal Route






    • China Antihistamine Drugs by Indication




      • Allergy




      • Urticaria




      • Dermatitis






    • China Antihistamine Drugs by End User




      • Hospitals




      • Clinics




      • Pharmaceutical Companies






    • Japan Outlook (USD Billion, 2018-2032)




    • Japan Antihistamine Drugs by Type




      • Sedating




      • Non-Sedating






    • Japan Antihistamine Drugs by Route of Administration




      • Oral Route




      • Parenteral Route




      • Rectal Route






    • Japan Antihistamine Drugs by Indication




      • Allergy




      • Urticaria




      • Dermatitis






    • Japan Antihistamine Drugs by End User




      • Hospitals




      • Clinics




      • Pharmaceutical Companies






    • India Outlook (USD Billion, 2018-2032)




    • India Antihistamine Drugs by Type




      • Sedating




      • Non-Sedating






    • India Antihistamine Drugs by Route of Administration




      • Oral Route




      • Parenteral Route




      • Rectal Route






    • India Antihistamine Drugs by Indication




      • Allergy




      • Urticaria




      • Dermatitis






    • India Antihistamine Drugs by End User




      • Hospitals




      • Clinics




      • Pharmaceutical Companies






    • Australia Outlook (USD Billion, 2018-2032)




    • Australia Antihistamine Drugs by Type




      • Sedating




      • Non-Sedating






    • Australia Antihistamine Drugs by Route of Administration




      • Oral Route




      • Parenteral Route




      • Rectal Route






    • Australia Antihistamine Drugs by Indication




      • Allergy




      • Urticaria




      • Dermatitis






    • Australia Antihistamine Drugs by End User




      • Hospitals




      • Clinics




      • Pharmaceutical Companies






    • Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)




    • Rest of Asia-Pacific Antihistamine Drugs by Type




      • Sedating




      • Non-Sedating






    • Rest of Asia-Pacific Antihistamine Drugs by Route of Administration




      • Oral Route




      • Parenteral Route




      • Rectal Route






    • Rest of Asia-Pacific Antihistamine Drugs by Indication




      • Allergy




      • Urticaria




      • Dermatitis






    • Rest of Asia-Pacific Antihistamine Drugs by End User




      • Hospitals




      • Clinics




      • Pharmaceutical Companies








  • Rest of the World Outlook (USD Billion, 2018-2032)




    • Rest of the World Antihistamine Drugs by Type




      • Sedating




      • Non-Sedating






    • Rest of the World Antihistamine Drugs by Route of Administration




      • Oral Route




      • Parenteral Route




      • Rectal Route






    • Rest of the World Antihistamine Drugs by Indication




      • Allergy




      • Urticaria




      • Dermatitis






    • Rest of the World Antihistamine Drugs by End User




      • Hospitals




      • Clinics




      • Pharmaceutical Companies






    • Middle East Outlook (USD Billion, 2018-2032)




    • Middle East Antihistamine Drugs by Type




      • Sedating




      • Non-Sedating






    • Middle East Antihistamine Drugs by Route of Administration




      • Oral Route




      • Parenteral Route




      • Rectal Route






    • Middle East Antihistamine Drugs by Indication




      • Allergy




      • Urticaria




      • Dermatitis






    • Middle East Antihistamine Drugs by End User




      • Hospitals




      • Clinics




      • Pharmaceutical Companies






    • Africa Outlook (USD Billion, 2018-2032)




    • Africa Antihistamine Drugs by Type




      • Sedating




      • Non-Sedating






    • Africa Antihistamine Drugs by Route of Administration




      • Oral Route




      • Parenteral Route




      • Rectal Route






    • Africa Antihistamine Drugs by Indication




      • Allergy




      • Urticaria




      • Dermatitis






    • Africa Antihistamine Drugs by End User




      • Hospitals




      • Clinics




      • Pharmaceutical Companies






    • Latin America Outlook (USD Billion, 2018-2032)




    • Latin America Antihistamine Drugs by Type




      • Sedating




      • Non-Sedating






    • Latin America Antihistamine Drugs by Route of Administration




      • Oral Route




      • Parenteral Route




      • Rectal Route






    • Latin America Antihistamine Drugs by Indication




      • Allergy




      • Urticaria




      • Dermatitis






    • Latin America Antihistamine Drugs by End User




      • Hospitals




      • Clinics




      • Pharmaceutical Companies







Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

Brief TOC

1 Report Prologue

2 Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3 Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

4 Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porters five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain

5.3 Investment Feasibility Analysis

5.4 Price Factor Analysis

6 Global Antihistamine drugs Market, by Type

6.1 Introduction

6.2 Sedating Antihistamine Drugs

6.2.1 Brompheniramine

6.2.2 Chlorpheniramine

6.2.3 Diphenhydramine

6.2.4 Doxylamine

6.2.5 Carbinoxamine

6.2.6 Others

6.3 Non-Sedating Antihistamine Drugs

6.3.1 Fexofenadine

6.3.2 Loratadine

6.3.3 Loratadine ODT

6.3.4 Others

7 Global Antihistamine Drugs Market, By Route of Administration

7.1 Introduction

7.2 Oral Route

7.3 Parenteral Route

7.3.1 Intramuscular

7.3.2 Subcutaneous

7.3.3 Intravenous Route

7.4 Rectal Route

8 Global Antihistamine Drugs Market, by Indication

8.1 Introduction

8.2 Allergy

8.3 Urticaria

8.4 Dermatitis

8.5 Others

9 Global Antihistamine Drugs Market by End User

9.1 Introduction

9.2 Hospitals

9.3 Clinics

9.4 Pharmaceutical Companies

9.5 Others

10 Global Antihistamine Drugs Market by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 U.S.

10.2.1.2 Canada

10.2.2 Latin America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 UK

10.3.1.4 Italy

10.3.1.5 Spain

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Republic of Korea

10.4.5 Australia

10.4.6 Rest of Asia Pacific

10.5 Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest of Middle East & Africa

11 Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

12 Company Profiles

12.1 Johnson & Johnson Consumer Inc.

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials

12.1.4 SWOT Analysis

12.2 Sanofi

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Bayer AG

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Pfizer

12.4.1 Company Overview

12.4.2 Product/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Merck Sharp & Dohme Corp.

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial Overview

12.5.4 Key Developments

12.6 Prestige Brands Holdings, Inc.

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.7 CVS Pharmacy

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View Point

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Prediction of Pharmaceutical Industry

14 Appendix

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.
Press Release
pr-img
Antihistamine Drugs Market is Expected to Grow at a CAGR of 9.8% by 2030
Logo
Dmca Cloudflare ssl
Paypal footer Ssl
Services Industry Expertise Consulting Services Articles How To Order FAQs
Our Company About US Careers Contact Us Terms & Conditions Privacy Policy
Banking Partners
Amex Mastercard1
Razerpay
Hdfcbank
Visa
✉  info@marketresearchfuture.com
📞  +1 (855) 661-4441(US)
📞  +44 1720 412 167(UK)

© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)